Best case scenario here is that the data is significant enough that discussions with pharma have been accelerated, thus putting long term holders out of future funding needs misery by announcing some partnership.
It’s an anomaly that Ath would have a halt like this with data so of it’s good I assume it will be very good.
Good luck to us all
Best case scenario here is that the data is significant enough...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $3.446K | 1.148M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 109813434 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 1195573 | 1 |
View Market Depth
| Last trade - 15.42pm 28/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |